Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers locate tumor-suppressor gene in fruit flies that controls cell production, death

16.07.2003


UT Southwestern Medical Center at Dallas researchers have discovered a tumor-suppressor gene that, in fruit flies, simultaneously restricts cell proliferation and promotes cell death, a process that may also play an important role in the genesis of cancer in humans.



Removal of the gene, hippo, resulted in tumor formation in every organ of the fruit fly. The findings, which are currently online, will appear in an upcoming issue of Cell.

"This is one of the few genes that has been discovered that directly controls two pathways, cell proliferation and cell apoptosis, or cell death," said Dr. Duojia Pan, assistant professor of physiology and senior author of the study. "Sustained growth of cancer cells requires activation of the cell proliferation machinery and suppression of a system called the apoptotic failsafe mechanism. The combination of suppressed cell death and deregulated cell production is likely a key element in cancer."


The researchers identified hippo by screening the fruit fly, or drosophila, genome for mutations that promoted abnormal tissue growth.

To determine the relationship between hippo and a similar protein found in humans, the researchers replaced the tumor-suppressor gene in fruit flies with a protein in humans called MST2. This resulted in the reduction of tumors in the fruit flies, leading researchers to hypothesize that MST2 plays a similar role in human-tumor suppression.

"We hypothesize that this protein (MST2) may be inactivated in some humans, causing the onset of tumor growth. Tumor suppression is important in humans because it is required to restrict abnormal growth of tissues," said Dr. Pan, the Virginia Murchison Linthicum Scholar in Medical Research.

The researchers report also that hippo is linked to two other tumor-suppressing genes, Salvador and warts.

"These three tumor-suppression genes may define a tumor suppression pathway that coordinately regulates cell proliferation and apoptosis," Dr. Pan said. "This pathway may also be involved in the formation of tumors in mammals."

Current research suggests that the human counterpart of Salvador is mutated in several cancer-cell lines.

"Our findings will stimulate investigations of this tumor suppression pathway in human cancers," Pan added.

By studying fruit flies, scientists have the ability to perform more experiments than in human studies because the fruit fly genome is easily mutated. Fruit flies carry approximately 70 percent of the same disease genes as humans.

Dr. Pan is currently studying three other tumor-suppressor genes, including PTEN, Tuberous Sclerosis 1(TSC1) and Tuberous Sclerosis 2 (TSC2). These genes have previously been identified as tumor-suppressor genes in humans.

Other researchers on the study were Drs. Jixin Dong, Jianbin Huang, and Shian Wu, all postdoctoral researchers in physiology.

The study was supported by the National Institutes of Health, the American Heart Association and the American Cancer Society.


###

Amy Shields | EurekAlert!
Further information:
http://www.swmed.edu/

More articles from Life Sciences:

nachricht Biophysicists reveal how optogenetic tool works
29.05.2020 | Moscow Institute of Physics and Technology

nachricht Mapping immune cells in brain tumors
29.05.2020 | University of Zurich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>